Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#106 most reported symptom for this vaccine
Injection site inflammation has been reported 76 times in association with DTP vaccination in VAERS. This represents 0.3% of all 23,850 reports for this vaccine.
Among these reports, 1 mentioned death (1.32%) and 1 involved hospitalization (1.3%).
Injection site inflammation is the #106 most frequently reported symptom for DTP out of 603 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 76 reports of Injection site inflammation after DTP vaccination may seem alarming, but context is critical.
The mortality rate of 1.32% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.